医药创新是推动产业升级的核心动力。多数国家加强医药创新顶层设计、强化资金支持、促进国内产学研合作、加强国际合作、健全和完善创新药价格支付机制和创新回报机制等，为本国医药创新和产业发展提供了强有力的制度保障。梳理了美国、欧盟、英国、日本在医药创新方面的政策和措施，提出了优化我国医药创新的策略，以期为我国医药创新提供借鉴和参考。

Medical innovation is the core driving force for promoting industrial upgrading. Most countries have provided strong institutional guarantees for their own pharmaceutical innovation and industrial development through policies such as strengthening top-level design of pharmaceutical innovation, enhancing financial support, promoting domestic industry university research cooperation, strengthening international cooperation, and improving innovative drug pricing payment mechanisms. This article summarizes the policies and measures of the United States, the European Union, the United Kingdom, and Japan in the field of pharmaceutical innovation, and proposes strategies to optimize China's pharmaceutical innovation, in order to provide reference and guidance for China's pharmaceutical innovation.

R951